+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients



Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients



Acta Tropica 80(2): 151-154



A total of 46 strains of Candida were collected from HIV infected patients, of which 25 strains were isolated from patients with oral candidiasis, and 21 strains were from mouthwash samples of asymptomatic carriers. The most common species isolated was Candida albicans (73.9%), followed by Candida tropicalis (21.7%). In vitro susceptibility of the strains to fluconazole and itraconazole was tested using minimum inhibitory concentration (MIC) studies by agar dilution technique. Out of the 18 strains of C. albicans isolated from mouthwash samples, four were resistant to fluconazole whereas only two were resistant to itraconazole. Out of 16 strains of C. albicans isolated from oral lesions, one was resistant to fluconazole where as all were sensitive to itraconazole. Among the other species of Candida tested, C. tropicalis gave higher MIC values to both drugs than other species such as Candida guillermondii and Candida krusei. In vitro MIC values correlated well with in vivo responses in patients. Hence, itraconazole may be used as an alternative in the treatment of candidiasis, which does not respond to fluconazole therapy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 003747461

Download citation: RISBibTeXText

PMID: 11600094

DOI: 10.1016/s0001-706x(01)00170-x


Related references

Comparison of itraconazole oral solution and fluconazole capsules in the treatment of oral and esophageal candidiasis in hiv infected patients preliminary results. Istituto Superiore Di Sanita Vii International Conference on Aids: Science Challenging Aids; Florence, Italy, June 16-21, 464p (Vol 1); 460p (Vol 2) Istituto Superiore Di Sanita: Rome, Italy Paper : 232, 1991

Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients. Aids Research and Human Retroviruses 15(16): 1413-1417, 1999

Single dose fluconazole versus 7 days itraconazole for treatment of oral candidiasis in HIV patients A prospective randomized study. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 33: 267, 1993

A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS. Clinical Infectious Diseases 26(6): 1368-1373, 1998

An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis. European Journal of Cancer 40(9): 1314-1319, 2004

Itraconazole oral solution versus fluconazole treatment of oropharyngeal candidiasis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 35: 244, 1995

Itraconazole oral solution compared with fluconazole for treatment of esophageal candidiasis. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS [Author] Eleventh International Conference on AIDS, Vol One One world: One hope : 17, 1996

Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients. Aids 12(9): 1033-1037, 1998

Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in aids patients. Brazilian Journal of Infectious Diseases 5(2): 60-66, 2001

Study of the safety and efficacy of a single oral fluconazole 150 mg in the treatment of patients with vaginal candidiasis. International Journal of Gynecology & Obstetrics (ABSTR Suppl.): 371, 1991

Testing the efficacy of fluconazole in treatment of oral and throat candidiasis in patients after kidney transplantation. Polski Tygodnik Lekarski 48(50-52): 867-869, 1993

A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis. Journal of Infectious Diseases 176(1): 227-232, 1997

Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis. Journal of International Medical Research 26(3): 159-170, 1998

Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis. Mycoses 39(Suppl. 1): 102-106, 1996